C-Path Awarded Grant to Continue Drug Safety Work The Critical Path Institute (C-Path) announced the receipt of a $4 million grant from the Agency for Healthcare Research and Quali
C-Path Makes Progress to Safely Speed Medical Discoveries to Market William Mattes of C-Path spoke at the Arizona Pavillion May 8th 2007 about the Predictive Safety Testing Consortium.
The Predictive Safety Testing Consortium enables companies to share and validate safety biomarkers. To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administratio
C-Path Adopts Rosetta Resolver® System for the PSTC Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-PathR
Raymond Woosley, M.D., Ph.D., Provides Expert Testimony in Congressional Hearings President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterd
New Corporate Members and Leaders for C-Path’s Predictive Safety Testing Consortium Announced The Critical Path Institute (C-Path) today announced seven new members that have recently joined the Predictive Safety Testing Con
FDA Release: The Predictive Safety Testing Consortium The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Sa
C-Path Forms Drug Testing Pact The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companie
C-Path to Spur Medical Innovation We all remember the Vioxx scare and authorities say it could happen again. However, the FDA is stepping up its efforts to improve
